DiaSorin LIAISON QuantiFERON-TB Gold Plus

QIAGEN and DiaSorin offer automated TB testing

QIAGEN and DiaSorin provide an automated workflow for QIAGEN’s QuantiFERON-TB Gold Plus Blood Collection Tubes on FDA approved and CE-marked DiaSorin LIAISON latest generation systems.

The LIAISON QuantiFERON-TB Gold Plus* solution allows laboratories to easily benefit from the performance of the QuantiFERON technology for latent tuberculosis (TB) testing on their DiaSorin immunodiagnostic system. This allows for flexible and efficient workflow for less hands-on time and improved time to results.

A lab in Doncaster receives multiple samples from communities susceptible to TB. Michelle Poole, Chief biomedical Scientist at Doncaster Royal Infirmary explains how the lab gets trustworthy and fast results with LIAISON QuantiFERON-TB Gold Plus.

Trusted QuantiFERON IGRA technology, proven LIAISON XL and LIAISON XS analyzers

The LIAISON QuantiFERON-TB Gold Plus* test was developed in a partnership between QIAGEN and DiaSorin to increase accessibility to the modern blood-based QuantiFERON technology. The automated TB testing solution offers LIAISON customers efficient, high-throughput detection with QFT-Plus as part of the system’s broad content menu. At the same time, QFT-Plus customers gain an option for full automation of laboratory handling to support TB control efforts.

QFT-Plus Blood Collection Tubes by QIAGEN
- Advanced QuantiFERON-TB Gold Plus tube science
- No change required to standard QuantiFERON-TB Gold Plus blood collection processes
- Single tube blood collection or direct draw to QFT-Plus Blood Collection Tubes
LIAISON XL and LIAISON XS Chemiluminescent Analysis by DiaSorin
- Familiar LIAISON XL and LIAISON XS analyzers and reagent integral kit format
- Fully automated testing solution
- 46 minutes to first result
- Analytical results fully traceable to individual tube ID

Automated testing for latent TB infection

Streamline your latent TB testing with the LIAISON QuantiFERON-TB Gold Plus* test.

See how two scientists are quickly and automatically detecting latent TB

Even in England and the United States, two of the richest countries in the world, there's a pressing need for latent TB testing. See how two committed scientists separated by one vast ocean rely on the same tool to detect latent TB before it spreads to others, or develops into the active and highly contagious form of the disease.

Read their story

Combining the blood based QuantiFERON technology with DiaSorin automation

The LIAISON QuantiFERON-TB Gold Plus* Test, developed by QIAGEN and DiaSorin offers streamlined laboratory automation for latent TB screening. Find out how the automated workflow pairs QIAGEN’s standard QuantiFERON-TB Gold Plus tube science with DiaSorin’s LIAISON QuantiFERON-TB Plus detection assay.

GET THE BROCHURE

*QuantiFERON-TB Gold Plus Blood Collection Tubes by QIAGEN and LIAISON Analyzer by DiaSorin.

LIAISON^® is a registered trademark of DiaSorin.

Product claims may differ from country to country based on regulations and approvals. Contact your country representative for further details.

DiaSorin LIAISON QuantiFERON-TB Gold Plus

QIAGEN and DiaSorin offer automated TB testing

Trusted QuantiFERON IGRA technology, proven LIAISON XL and LIAISON XS analyzers

QFT-Plus Blood Collection Tubes by QIAGEN

LIAISON XL and LIAISON XS Chemiluminescent Analysis by DiaSorin

See how two scientists are quickly and automatically detecting latent TB

Combining the blood based QuantiFERON technology with DiaSorin automation